STOCK TITAN

[8-K] Celularity Inc. Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Savers Value Village, Inc. (SVV) filed a Form 144 indicating that an insider intends to sell up to 600 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. Based on the reference price in the notice, the stake is valued at $6,306. With 157,451,564 shares outstanding, the proposed sale equals roughly 0.0004 % of the float, implying negligible market impact.

The seller, identified in the three-month sales table as Richard Medway, has already disposed of 36,513 shares between May and July 2025 for gross proceeds of about $402 k. The 600 shares originate from a stock option granted 12 Jun 2019 and exercised for cash on the planned sale date.

This filing is routine compliance with Rule 144 for restricted/control securities. Given the de-minimis size relative to daily volume and market cap, the event is unlikely to influence valuation, though investors may note the ongoing insider selling trend.

Savers Value Village, Inc. (SVV) ha presentato un modulo Form 144 indicando che un dirigente intende vendere fino a 600 azioni ordinarie tramite Fidelity Brokerage Services a partire dal 22 luglio 2025. In base al prezzo di riferimento indicato nella comunicazione, la partecipazione ha un valore di circa 6.306 $. Con 157.451.564 azioni in circolazione, la vendita proposta rappresenta circa lo 0,0004 % del flottante, suggerendo un impatto di mercato trascurabile.

Il venditore, identificato nella tabella delle vendite trimestrali come Richard Medway, ha già ceduto 36.513 azioni tra maggio e luglio 2025 per un ricavo lordo di circa 402.000 $. Le 600 azioni derivano da un'opzione azionaria concessa il 12 giugno 2019 ed esercitata in contanti nella data prevista per la vendita.

Questa comunicazione è una conformità di routine alla Regola 144 relativa ai titoli vincolati o di controllo. Considerata la dimensione minima rispetto al volume giornaliero e alla capitalizzazione di mercato, l'evento difficilmente influenzerà la valutazione, anche se gli investitori potrebbero notare la tendenza continua alla vendita da parte degli insider.

Savers Value Village, Inc. (SVV) presentó un Formulario 144 indicando que un insider planea vender hasta 600 acciones comunes a través de Fidelity Brokerage Services a partir del 22 de julio de 2025. Según el precio de referencia en el aviso, la participación está valorada en 6,306 $. Con 157,451,564 acciones en circulación, la venta propuesta equivale aproximadamente al 0.0004 % del float, lo que implica un impacto de mercado insignificante.

El vendedor, identificado en la tabla de ventas trimestrales como Richard Medway, ya ha vendido 36,513 acciones entre mayo y julio de 2025 por ingresos brutos de alrededor de 402,000 $. Las 600 acciones provienen de una opción sobre acciones otorgada el 12 de junio de 2019 y ejercida en efectivo en la fecha prevista para la venta.

Esta presentación es un cumplimiento rutinario con la Regla 144 para valores restringidos/de control. Dado el tamaño mínimo en relación con el volumen diario y la capitalización de mercado, es poco probable que el evento influya en la valoración, aunque los inversores pueden notar la tendencia continua de ventas por parte de insiders.

Savers Value Village, Inc. (SVV)는 내부자가 2025년 7월 22일 이후 Fidelity Brokerage Services를 통해 최대 600주의 보통주를 판매할 계획임을 나타내는 Form 144를 제출했습니다. 공지에 명시된 기준 가격에 따르면 이 지분의 가치는 6,306달러로 평가됩니다. 총 발행 주식 수가 157,451,564주인 가운데, 제안된 판매는 유통 주식수의 약 0.0004%에 해당하여 시장에 미치는 영향은 미미할 것으로 보입니다.

3개월 판매 내역 표에 Richard Medway로 명시된 판매자는 2025년 5월부터 7월 사이에 이미 36,513주를 처분해 약 40만 2천 달러의 총수익을 올렸습니다. 이번 600주는 2019년 6월 12일 부여된 주식 옵션에서 나온 것으로, 계획된 판매일에 현금으로 행사되었습니다.

이 제출은 제한/통제 증권에 대한 규칙 144 준수를 위한 일상적인 절차입니다. 일일 거래량 및 시가총액에 비해 미미한 규모이므로 평가에 미치는 영향은 거의 없을 것으로 보이나, 투자자들은 내부자 매도 추세가 계속되고 있음을 주목할 수 있습니다.

Savers Value Village, Inc. (SVV) a déposé un formulaire 144 indiquant qu’un initié prévoit de vendre jusqu’à 600 actions ordinaires via Fidelity Brokerage Services à partir du 22 juillet 2025. Selon le prix de référence mentionné dans l’avis, la participation est évaluée à 6 306 $. Avec 157 451 564 actions en circulation, la vente proposée représente environ 0,0004 %

Le vendeur, identifié dans le tableau des ventes sur trois mois comme Richard Medway, a déjà cédé 36 513 actions entre mai et juillet 2025 pour un produit brut d’environ 402 000 $. Les 600 actions proviennent d’une option d’achat d’actions accordée le 12 juin 2019 et exercée en espèces à la date prévue de la vente.

Ce dépôt est une conformité de routine avec la règle 144 concernant les titres restreints/de contrôle. Étant donné la taille minime par rapport au volume quotidien et à la capitalisation boursière, cet événement est peu susceptible d’influencer la valorisation, bien que les investisseurs puissent noter la tendance continue des ventes par les initiés.

Savers Value Village, Inc. (SVV) hat ein Formular 144 eingereicht, das anzeigt, dass ein Insider beabsichtigt, bis zu 600 Stammaktien über Fidelity Brokerage Services ab dem 22. Juli 2025 zu verkaufen. Basierend auf dem Referenzpreis in der Mitteilung wird die Beteiligung auf 6.306 $ geschätzt. Bei 157.451.564 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,0004 % des Streubesitzes, was auf eine vernachlässigbare Marktwirkung hindeutet.

Der Verkäufer, in der Dreimonat-Verkaufstabelle als Richard Medway aufgeführt, hat bereits zwischen Mai und Juli 2025 36.513 Aktien veräußert und dabei Bruttoerlöse von etwa 402.000 $ erzielt. Die 600 Aktien stammen aus einer am 12. Juni 2019 gewährten Aktienoption, die am geplanten Verkaufstag bar ausgeübt wurde.

Diese Meldung ist eine routinemäßige Einhaltung der Regel 144 für beschränkte/kontrollierte Wertpapiere. Angesichts der minimalen Größe im Verhältnis zum Tagesvolumen und der Marktkapitalisierung ist es unwahrscheinlich, dass das Ereignis die Bewertung beeinflusst, obwohl Anleger den anhaltenden Insider-Verkaufstrend zur Kenntnis nehmen könnten.

Positive
  • None.
Negative
  • Ongoing insider selling: The filer disposed of 36,513 shares in the past three months and now plans an additional 600-share sale, which some investors may view cautiously despite the small size.

Insights

600-share Form 144; negligible vs float; cumulative 36k shares sold; transaction routine; unlikely to move SVV valuation.

The proposed 600-share sale represents just 0.0004 % of Savers Value Village’s outstanding stock and follows earlier dispositions totalling 36,513 shares (~0.02 % of float). Such volumes will not affect supply-demand dynamics or dilute existing holders. The shares stem from an option exercised the same day, signalling normal liquidity management rather than strategic exit. Absent wider insider selling or adverse fundamentals, market impact is neutral.

Insider’s continued disposals small but persistent; monitor alignment, though current filing alone lacks material significance.

Rule 144 disclosures enhance transparency on insider trading. While 600 shares is trivial, four earlier sales in three months show the individual gradually trimming exposure. Percentages remain immaterial, yet persistent selling can draw scrutiny if paired with deteriorating operations. Governance risk appears low; the filer certifies no undisclosed negative information. Investors should simply watch for accelerating volumes or additional insiders following suit.

Savers Value Village, Inc. (SVV) ha presentato un modulo Form 144 indicando che un dirigente intende vendere fino a 600 azioni ordinarie tramite Fidelity Brokerage Services a partire dal 22 luglio 2025. In base al prezzo di riferimento indicato nella comunicazione, la partecipazione ha un valore di circa 6.306 $. Con 157.451.564 azioni in circolazione, la vendita proposta rappresenta circa lo 0,0004 % del flottante, suggerendo un impatto di mercato trascurabile.

Il venditore, identificato nella tabella delle vendite trimestrali come Richard Medway, ha già ceduto 36.513 azioni tra maggio e luglio 2025 per un ricavo lordo di circa 402.000 $. Le 600 azioni derivano da un'opzione azionaria concessa il 12 giugno 2019 ed esercitata in contanti nella data prevista per la vendita.

Questa comunicazione è una conformità di routine alla Regola 144 relativa ai titoli vincolati o di controllo. Considerata la dimensione minima rispetto al volume giornaliero e alla capitalizzazione di mercato, l'evento difficilmente influenzerà la valutazione, anche se gli investitori potrebbero notare la tendenza continua alla vendita da parte degli insider.

Savers Value Village, Inc. (SVV) presentó un Formulario 144 indicando que un insider planea vender hasta 600 acciones comunes a través de Fidelity Brokerage Services a partir del 22 de julio de 2025. Según el precio de referencia en el aviso, la participación está valorada en 6,306 $. Con 157,451,564 acciones en circulación, la venta propuesta equivale aproximadamente al 0.0004 % del float, lo que implica un impacto de mercado insignificante.

El vendedor, identificado en la tabla de ventas trimestrales como Richard Medway, ya ha vendido 36,513 acciones entre mayo y julio de 2025 por ingresos brutos de alrededor de 402,000 $. Las 600 acciones provienen de una opción sobre acciones otorgada el 12 de junio de 2019 y ejercida en efectivo en la fecha prevista para la venta.

Esta presentación es un cumplimiento rutinario con la Regla 144 para valores restringidos/de control. Dado el tamaño mínimo en relación con el volumen diario y la capitalización de mercado, es poco probable que el evento influya en la valoración, aunque los inversores pueden notar la tendencia continua de ventas por parte de insiders.

Savers Value Village, Inc. (SVV)는 내부자가 2025년 7월 22일 이후 Fidelity Brokerage Services를 통해 최대 600주의 보통주를 판매할 계획임을 나타내는 Form 144를 제출했습니다. 공지에 명시된 기준 가격에 따르면 이 지분의 가치는 6,306달러로 평가됩니다. 총 발행 주식 수가 157,451,564주인 가운데, 제안된 판매는 유통 주식수의 약 0.0004%에 해당하여 시장에 미치는 영향은 미미할 것으로 보입니다.

3개월 판매 내역 표에 Richard Medway로 명시된 판매자는 2025년 5월부터 7월 사이에 이미 36,513주를 처분해 약 40만 2천 달러의 총수익을 올렸습니다. 이번 600주는 2019년 6월 12일 부여된 주식 옵션에서 나온 것으로, 계획된 판매일에 현금으로 행사되었습니다.

이 제출은 제한/통제 증권에 대한 규칙 144 준수를 위한 일상적인 절차입니다. 일일 거래량 및 시가총액에 비해 미미한 규모이므로 평가에 미치는 영향은 거의 없을 것으로 보이나, 투자자들은 내부자 매도 추세가 계속되고 있음을 주목할 수 있습니다.

Savers Value Village, Inc. (SVV) a déposé un formulaire 144 indiquant qu’un initié prévoit de vendre jusqu’à 600 actions ordinaires via Fidelity Brokerage Services à partir du 22 juillet 2025. Selon le prix de référence mentionné dans l’avis, la participation est évaluée à 6 306 $. Avec 157 451 564 actions en circulation, la vente proposée représente environ 0,0004 %

Le vendeur, identifié dans le tableau des ventes sur trois mois comme Richard Medway, a déjà cédé 36 513 actions entre mai et juillet 2025 pour un produit brut d’environ 402 000 $. Les 600 actions proviennent d’une option d’achat d’actions accordée le 12 juin 2019 et exercée en espèces à la date prévue de la vente.

Ce dépôt est une conformité de routine avec la règle 144 concernant les titres restreints/de contrôle. Étant donné la taille minime par rapport au volume quotidien et à la capitalisation boursière, cet événement est peu susceptible d’influencer la valorisation, bien que les investisseurs puissent noter la tendance continue des ventes par les initiés.

Savers Value Village, Inc. (SVV) hat ein Formular 144 eingereicht, das anzeigt, dass ein Insider beabsichtigt, bis zu 600 Stammaktien über Fidelity Brokerage Services ab dem 22. Juli 2025 zu verkaufen. Basierend auf dem Referenzpreis in der Mitteilung wird die Beteiligung auf 6.306 $ geschätzt. Bei 157.451.564 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,0004 % des Streubesitzes, was auf eine vernachlässigbare Marktwirkung hindeutet.

Der Verkäufer, in der Dreimonat-Verkaufstabelle als Richard Medway aufgeführt, hat bereits zwischen Mai und Juli 2025 36.513 Aktien veräußert und dabei Bruttoerlöse von etwa 402.000 $ erzielt. Die 600 Aktien stammen aus einer am 12. Juni 2019 gewährten Aktienoption, die am geplanten Verkaufstag bar ausgeübt wurde.

Diese Meldung ist eine routinemäßige Einhaltung der Regel 144 für beschränkte/kontrollierte Wertpapiere. Angesichts der minimalen Größe im Verhältnis zum Tagesvolumen und der Marktkapitalisierung ist es unwahrscheinlich, dass das Ereignis die Bewertung beeinflusst, obwohl Anleger den anhaltenden Insider-Verkaufstrend zur Kenntnis nehmen könnten.

false 0001752828 0001752828 2025-06-23 2025-06-23 0001752828 CELU:ClassCommonStock0.0001ParValuePerShareMember 2025-06-23 2025-06-23 0001752828 CELU:WarrantsEachExercisableForOnetenthOfOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2025-06-23 2025-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 23, 2025

 

 

 

Celularity Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38914   83-1702591

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

170 Park Ave

Florham Park, New Jersey

  07932
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (908) 768-2170

 

N/A

(Former name or former address, if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share   CELU   The Nasdaq Stock Market LLC
Warrants, each exercisable for one-tenth of one share of Class A Common Stock at an exercise price of $11.50 per share   CELUW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On June 23, 2025, Celularity Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (“the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of 739,286 shares of the Company’s Class A common stock, par value $0.0001 (the “Common Stock”) at a purchase price of $1.40 per share of Common Stock.

 

As part of the Private Placement, pursuant to a warrant adjustment agreement, the Company agreed with the Purchasers to revise the exercise price of certain warrants held by the Purchasers in the aggregate amount of 1,311,093 to $2.50 per share and extend the expiration date of such warrants to June 30, 2030.

 

The closing of the Private Placement is expected to occur during the week of July 21, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds to the Company from the Private Placement are expected to be $1,035,000, before deducting estimated offering expenses payable by the Company. The Company intends to use the net proceeds received from the Private Placement for working capital and general corporate purposes.

 

The Purchase Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions. The foregoing descriptions of terms and conditions of the Purchase Agreement, and the Warrant Adjustment Agreement do not purport to be complete and are qualified in their entirety by the full text of the form of the Purchase Agreement and the form of Warrant Adjustment Agreement, which are attached hereto as Exhibits 10.1 and 10.2, respectively.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information contained in Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 3.02.

 

-2-

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
   
10.1   Form of Securities Purchase Agreement
10.2   Form of Warrant Adjustment Agreement
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

-3-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CELULARITY INC.
Dated: July 22, 2025  
  By:

/s/ Robert J. Hariri

  Name: Robert J. Hariri, M.D., Ph.D.
  Title: Chairman and CEO

 

-4-

 

 

FAQ

What did Savers Value Village (SVV) disclose in its latest Form 144 filing?

An insider plans to sell up to 600 SVV common shares valued at $6,306 on or after 22 Jul 2025.

How many SVV shares will be sold and what is the estimated market value?

600 shares with an aggregate market value of $6,306 according to the filing.

Who is the insider selling SVV stock and how much has he sold recently?

Richard Medway sold 36,513 shares in the past three months for approximately $402 k and now plans to sell 600 more.

What percentage of SVV’s outstanding shares does the proposed sale represent?

Roughly 0.0004 % of the 157,451,564 shares outstanding.

On which exchange and through which broker will the SVV shares be sold?

The shares are slated for sale on the NYSE via Fidelity Brokerage Services LLC.
Celularity Inc

NASDAQ:CELUW

CELUW Rankings

CELUW Latest News

CELUW Latest SEC Filings

CELUW Stock Data

14.37M
Biotechnology
Pharmaceutical Preparations
Link
United States
FLORHAM PARK